Annovis Bio has partnered with NeuroRPM to implement a new US FDA-cleared AI platform. The biotech company is developing an ...

The START Center for Cancer Research (START), a community-based network of clinical trial sites, has partnered with Trialing, ...

When the truth is doctored, lives hang in the balance.

What’s happening to our planet is having an undeniable and devastating impact across every aspect of human health. What harms ...

When we investigate millennial healthcare professionals (HCPs), we see a generation experiencing a clash of two existences.

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to ...

Discover how AI, analytics and real-world data are reshaping Medical Affairs. Explore how AI, advanced analytics, and expanding access to real-world data are transforming Medical Affairs into a more ...

Discover how teams from across Inizio provided a range of integrated services to give a client's product the best chance of launch success.

Bristol Myers Squibb (BMS) has evolved its Standing in the Gaap programme by launching one of the largest multiple myeloma (MM) surveys ever conducted in the US. Designed to help identify the factors ...

One-carbon Therapeutics has partnered with Tempus AI to advance the clinical development of TH9619, a small molecule inhibitor of overexpressed enzymes in cancer cells. One-carbon Therapeutics, ...

Eli Lilly (Lilly) has agreee to acquire Centessa Pharmaceuticals in a deal worth up to $7.8bn. Centessa is a clinical-stage company focused on developing treatments for excessive daytime sleepiness ...